Results 1 to 10 of about 4,068,473 (311)

Assessment of Potential Drug‐Drug Interactions in Hospitalized Patients With Cardiovascular Diseases at Kenyatta National Hospital, Nairobi, Kenya: A Cross‐Sectional Study [PDF]

Health Science Reports
Background and Aim Drug–drug interactions (DDIs) occur when the pharmacological effect of one medication is altered by the concurrent administration of another, potentially leading to reduced therapeutic efficacy or increased risk of adverse effects ...
Brenda Koech, Ermias Terefe
doaj   +2 more sources

Teachers’ acute cardiovascular response to observed classroom disruptions and resulting chronic endocrine stress. Analysis of dynamic effects with global assessments for state space grids [PDF]

Frontiers in Physiology
IntroductionClassroom disruptions are a major source of stress for teachers. However, teachers’acute physiological stress response to classroom disruptions and its consequences for chronic stress remain poorly understood.MethodsThe present study assessed
Niklas Litzenberger, Gabriel Jenni, Alexander Wettstein   +2 more
doaj   +2 more sources

Potential Cardiovascular Drug Interactions in Egypt: Incidence, Outcomes, Mechanism, and Management [PDF]

Kafrelsheikh Veterinary Medical Journal, 2021
Background/aim: Cardiovascular diseases usually involve multiple drug co-administration giving the potential for many drug-drug interactions. Limited data is available regarding drug interactions of cardiovascular diseases in Egypt.
Khaled Sobhy, Omar AbdelMagged, Khloud Abdelaty, Dalia Khalil, Mohamed Abdelgaied   +4 more
doaj   +1 more source

Diet-gut microbiota interactions on cardiovascular disease

Computational and Structural Biotechnology Journal, 2022
Cardiovascular diseases (CVD) are a group of disorders of the heart and blood vessels and remain the leading cause of morbidity and mortality worldwide.
Xufei Zhang, Philippe Gérard
doaj   +1 more source

Characterising within-hospitalSARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves

Nature Communications, 2022
SARS-CoV-2 has resulted in multiple outbreaks in hospitals, but identifying transmission events is challenging. Here, the authors combine whole genome sequencing and epidemiological data from the first two waves of the pandemic at a UK hospital trust and
Benjamin B. Lindsey, Ch. Julián Villabona-Arenas, Finlay Campbell, Alexander J. Keeley, Matthew D. Parker, Dhruv R. Shah, Helena Parsons, Peijun Zhang, Nishchay Kakkar, Marta Gallis, Benjamin H. Foulkes, Paige Wolverson, Stavroula F. Louka, Stella Christou, Amy State, Katie Johnson, Mohammad Raza, Sharon Hsu, Thibaut Jombart, Anne Cori, Sheffield COVID-19 Genomics Group, The COVID-19 Genomics UK (COG-UK) consortium, CMMID COVID-19 working group, Cariad M. Evans, David G. Partridge, Katherine E. Atkins, Stéphane Hué, Thushan I. de Silva   +27 more
doaj   +1 more source

Altered subgenomic RNA abundance provides unique insight into SARS-CoV-2 B.1.1.7/Alpha variant infections

Communications Biology, 2022
Matthew Parker et al. use the ARTIC network tiled amplicon PCR and Oxford Nanopore sequencing of thousands of SARS-CoV-2 samples to detect subgenomic RNA changes in the B.1.1.7 lineage endemic in the UK in late 2020/early 2021.
Matthew D. Parker, Hazel Stewart, Ola M. Shehata, Benjamin B. Lindsey, Dhruv R. Shah, Sharon Hsu, Alexander J. Keeley, David G. Partridge, Shay Leary, Alison Cope, Amy State, Katie Johnson, Nasar Ali, Rasha Raghei, Joe Heffer, Nikki Smith, Peijun Zhang, Marta Gallis, Stavroula F. Louka, Hailey R. Hornsby, Hatoon Alamri, Max Whiteley, Benjamin H. Foulkes, Stella Christou, Paige Wolverson, Manoj Pohare, Samantha E. Hansford, Luke R. Green, Cariad Evans, Mohammad Raza, Dennis Wang, Andrew E. Firth, James R. Edgar, Silvana Gaudieri, Simon Mallal, The COVID-19 Genomics UK (COG-UK) consortium, Mark O. Collins, Andrew A. Peden, Thushan I. de Silva   +38 more
doaj   +1 more source

Prevalence and Clinical Significance of Drug–Drug and Drug–Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece

Pharmaceutics, 2021
Background: Drug interactions represent a major issue in clinical settings, especially for critically ill patients such as those with cardiovascular disease (CVD) who require cardiothoracic surgery (CTS) and receive a high number of different medications.
Marios Spanakis, Maria Melissourgaki, George Lazopoulos, Athina E. Patelarou, Evridiki Patelarou   +4 more
doaj   +1 more source

Polypharmacy and potential drug-drug interactions in adult outpatients receiving cardiovascular drugs

National Journal of Physiology, Pharmacy and Pharmacology, 2023
Background: The prevalence of polypharmacy is rising and is particularly relevant to cardiovascular diseases. Assessing the extent of polypharmacy and potential drug-drug interactions (pDDIs) is an essential first step in improving safe and rational use ...
Onkar Kiran Manjul, Shraddha Milind Pore, Nimish Ravindra Halasawadekar, Atmik Singh, Nitin Natthuji Puram, Shreyas Ramchandra Burute   +5 more
doaj   +1 more source

Possible Potential Effects of Honey and Its Main Components Against Covid-19 Infection

Dose-Response, 2021
Coronavirus disease 2019 (COVID-19) is a viral pneumonia that is spreading rapidly worldwide. The main feature of this disease is a severe acute respiratory syndrome and caused by coronavirus 2 (SARS-CoV-2).
Farshid Abedi, Saeedeh Ghasemi, Tahereh Farkhondeh, Mohsen Azimi-Nezhad, Mehdi Shakibaei, Saeed Samarghandian   +5 more
doaj   +1 more source

Targeting Lipid—Ion Channel Interactions in Cardiovascular Disease

Frontiers in Cardiovascular Medicine, 2022
General lipid-lowering strategies exhibit clinical benefit, however, adverse effects and low adherence of relevant pharmacotherapies warrants the investigation into distinct avenues for preventing dyslipidemia-induced cardiovascular disease. Ion channels
Emma C. Hudgins, Adam M. Bonar, Thanh Nguyen, Ibra S. Fancher   +3 more
doaj   +1 more source